Instil Bio Announces Poster Presentations at the 2021 Society for Immunotherapy of Cancer (SITC) Annual MeetingGlobeNewsWire • 11/15/21
Instil Bio Receives IND Clearance to Initiate a Phase 2 Clinical Trial for Patients with Advanced MelanomaGlobeNewsWire • 09/13/21
Instil Bio Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/12/21
Instil Bio Reports First Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/13/21
Instil Bio Presents Clinical Data in Metastatic Melanoma in a Late-Breaking e-Poster at the 2021 American Association for Cancer Research (AACR) Annual MeetingGlobeNewsWire • 04/12/21
Instil Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 03/23/21